Article
Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
15 Dec 2021
Abstract excerpt
Glioblastoma multiforme (GBM) is the most aggressive malignant primary central nervous system tumor. Although surgery, radiotherapy, and chemotherapy treatments are available, the 5-year survival rate of GBM is only 5.8%. Therefore, it is imperative to find novel biomarker for the prognosis and treatment of GBM. In this study, a total of 141 differentially expressed genes (DEGs) in GBM were identified by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
